Clinical Report: Low-Dose PFAS Exposure Alters Cellular Metabolism
Overview
Revise to clarify the significance of minimal intracellular accumulation in relation to metabolic changes.
Background
Per- and polyfluoroalkyl substances (PFAS) are persistent environmental pollutants linked to various health risks. Understanding their impact on cellular metabolism is crucial, as these substances are commonly found in human blood and associated with adverse health outcomes. This study provides insights into the molecular mechanisms by which low-dose PFAS exposure may influence cellular functions.
Data Highlights
No substantial numerical data or trial results were provided in the article.
Key Findings
- Low-dose PFAS exposure alters cellular metabolism despite minimal intracellular accumulation.
- PFOS levels increased rapidly within the first 24 hours but stabilized thereafter.
- PFOA remained below the detection limit throughout the study.
- Transcriptomic profiling revealed changes in oxidative stress pathways and lipid metabolism.
- Lipidomic analyses indicated shifts consistent with membrane remodeling and altered lipid composition.
- PFAS toxicity may arise from interactions with cellular membranes rather than sustained accumulation.
Clinical Implications
Clinicians should be aware that low-level PFAS exposure can lead to significant metabolic changes, potentially affecting patient health. Monitoring and counseling regarding PFAS exposure may be necessary, especially in populations at risk.
Conclusion
The study underscores the need for further research into the health implications of low-dose PFAS exposure, particularly regarding metabolic alterations and their potential long-term effects.
References
- The Analytical Scientist, Elevated PFAS Linked to Changes in Blood Lipids, 2026 -- Elevated PFAS Linked to Changes in Blood Lipids
- Archives of Toxicology, Effects of perfluoroalkyl substances (PFAS) and their combinations on lipid metabolism in differentiated HepaRG cells as a human hepatocyte model, 2023 -- Effects of perfluoroalkyl substances (PFAS) and their combinations on lipid metabolism
- Archives of Toxicology, Role of Per- and Polyfluoroalkyl Substances in Cancer Development, 2024 -- Role of Per- and Polyfluoroalkyl Substances in Cancer Development
- Archives of Toxicology, Effects of Perfluorooctanoic Acid (PFOA), Perfluorooctane Sulfonic Acid (PFOS), and Perfluorononanoic Acid (PFNA) on Triglyceride Levels and Cholesterogenic Gene Expression in Human HepaRG Liver Cells, 2020 -- Effects of PFOA, PFOS, and PFNA on Triglyceride Levels
- US EPA, Per- and Polyfluoroalkyl Substances (PFAS) -- Per- and Polyfluoroalkyl Substances (PFAS)
- PubMed, Global Serum Per- and Polyfluoroalkyl Substances Exposures and Their Correlation with Lipids: A Systematic Review and Meta-Analysis -- Global Serum Per- and Polyfluoroalkyl Substances Exposures
- Per- and Polyfluoroalkyl Substances (PFAS) | US EPA
- Global Serum Per- and Polyfluoroalkyl Substances Exposures and Their Correlation with Lipids: A Systematic Review and Meta-Analysis - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
